Press Release

Biopharmaceutical Sector Supports 84,000 Florida Jobs

PhRMA September 12, 2013

WASHINGTON, D.C. (September 16, 2013) – Working in collaboration with Florida clinicians and research institutions, America’s biopharmaceutical research companies have conducted more than 7,800 clinical trials of new medicines in Florida over the last 14 years, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

These trials have benefited thousands of Floridian patients, the state’s economy and the advancement of science and patient care.  The new report – “Research in Your Backyard:  Pharmaceutical Clinical Trials in Florida” – also shows that the biopharmaceutical sector supported nearly 84,000 Florida jobs in 2011. 

The report was released today at a conference in Tampa sponsored by BioFlorida on the importance of life sciences and biopharmaceutical research to the state. 

“Today’s findings in the “Research in Your Backyard” report underscore the importance of our efforts to ensure that the state has a strong research infrastructure,” said Nancy Bryan, President and CEO of BioFlorida.  “Fortunately, policymakers and legislators in the state understand the necessity of a strong biopharmaceutical presence to patients and the economy.  With so many clinical trials and collaborations between biopharmaceutical companies and Florida’s premiere research institutions, we are helping to promote a healthier America while creating good jobs.”

Nearly half of the clinical trials of new medicines have been aimed at the most debilitating chronic diseases – cancer, diabetes, heart disease, stroke, asthma and mental illnesses.  And nearly 700 of those trials are still active and recruiting patients.

“For some patients, a clinical trial of a new medicine can be a real therapeutic option to discuss with health care providers,” said Matthew Bennett, Senior Vice President of PhRMA.  

Clinical trials are being conducted in communities across Florida, including Jacksonville, Miami, St. Petersburg, Orlando, West Palm Beach, Tampa, Pensacola, Orlando, St. Augustine, Lake City and many others. 

The report also details how the biopharmaceutical sector is boosting Florida employment and the state’s economy.  Nearly 84,000 jobs were sector-supported in the state in 2011, including  22,438 workers employed directly by biopharmaceutical companies. Direct biopharmaceutical wages and benefits resulted in about $1.6 billion in 2011 compensation, generating more than $276 million in tax money for the state and federal governments. 

Biopharmaceutical companies are committed to the development of effective new medicines and they are working to ensure that patients have access to those treatments through the industry-supported Partnership for Prescription Assistance (PPA).  The PPA is a single point of access to more than 475 pharmaceutical assistance programs – including nearly 200  sponsored by biopharmaceutical companies – that provide free or nearly free medicines to uninsured and financially struggling patients.   The program has matched nearly 600,000 Floridians to assistance programs since 2005 at a time of high unemployment.  Patients can contact the PPA through a toll-free number (1-888-477-2669) or online at   

The new report is available at and includes a list of institutions in the state conducting tests of new medicines by disease, as well as clinical trials still available for participation.    



About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested over $500 billion in the search for new treatments and cures, including an estimated $48.5 billion in 2012 alone.

Find PhRMA Online:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For information on ensuring the flow of medicines during public health emergencies, visit


About BioFlorida

BioFlorida ( is the voice of Florida’s bioscience industry, representing more than 3,000 companies and research organizations in the biotechnology, pharmaceutical and medical device fields that employ 61,000 Floridians. BioFlorida’s member-driven initiatives provide a strong business climate for production of quality, life-improving technologies; and promote economic benefits to the state.